Sumitomo Pharma Co., Ltd.: payments to clinicians
Sumitomo Pharma Co., Ltd.'s payments to clinicians fell 82% in 2025, to $13,994 across 5 people. Most of it (55%) was consulting fees, then travel and lodging (33%). The largest single recipient (Psychiatry & Neurology, Psychiatry, Maryland) received $5,602.
| Program year | Total | Payments | Clinicians paid |
|---|---|---|---|
| 2025 | $13,994 | 59 | 5 |
| 2024 | $76,925 | 88 | 11 |
Largest recipients in 2025
| # | Clinician | Specialty | Location | Amount |
|---|---|---|---|---|
| 1 | Akira Sawa, M.D. | Psychiatry & Neurology, Psychiatry | Baltimore, MD | $5,602 |
| 2 | Takuya Saito | Psychiatry & Neurology, Child & Adolescent Psychiatry | Suginami, TOKYO | $4,092 |
| 3 | Lejla Vajzovic, M.D. | Ophthalmology | Durham, NC | $2,200 |
| 4 | John Kane | Psychiatry & Neurology, Psychiatry | Glen Oaks, NY | $1,400 |
| 5 | Robert L. Findling, MD | Psychiatry & Neurology, Child & Adolescent Psychiatry | Cleveland, OH | $700.00 |
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records